Rapidity of CNS Effect on Photoparoxysmal Response for Brivaracetam vs. Levetiracetam: A Randomized, Double-blind, Crossover Trial in Photosensitive Epilepsy Patients-Reference-Cited by-同舟云学术

Rapidity of CNS Effect on Photoparoxysmal Response for Brivaracetam vs. Levetiracetam: A Randomized, Double-blind, Crossover Trial in Photosensitive Epilepsy Patients

Published:2020-09-19 Issue:10 Volume:34 Page:1075-1086
ISSN:1172-7047
Container-title:CNS Drugs
language:en
Short-container-title:CNS Drugs

Author:

Reed Ronald C.,Rosenfeld William E.,Lippmann Susan M.,Eijkemans Rene M. J. C.,Kasteleijn-Nolst Trenité Dorothee G. A.

Funder

UCB US

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical)

Link

https://link.springer.com/content/pdf/10.1007/s40263-020-00761-1.pdf

Reference43 articles.

1. Kenda BM, Matagne AC, Talaga PE, Pasau PM, Differding E, Lallemand BI, et al. Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity. J Med Chem. 2004;47:530–49. https://doi.org/10.1021/jm030913e.

2. Gillard M, Fuks B, Leclercq K, Matagne A. Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: relationship to anticonvulsant properties. Eur J Pharmacol. 2011;664:36–44. https://doi.org/10.1016/j.ejphar.2011.04.064.

3. Matagne A, Margineanu D-G, Kenda B, Michel P, Klitgaard H. Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A. Br J Pharmacol. 2008;154:1662–71. https://doi.org/10.1038/bjp.2008.198.

4. Klitgaard H, Matagne A, Nicolas J-M, Gillard M, Lamberty Y, De Ryck M, et al. Brivaracetam: rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment. Epilepsia. 2016;57(4):538–48. https://doi.org/10.1111/epi.13340.

5. Wood MD, Gillard M. Evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein. Epilepsia. 2017;58(2):255–62. https://doi.org/10.1111/epi.13638.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Narrative Review of Brivaracetam: Preclinical Profile and Clinical Benefits in the Treatment of Patients with Epilepsy;Advances in Therapy;2024-05-29

2. Research Status, Synthesis and Clinical Application of Antiepileptic Drugs;Current Medicinal Chemistry;2024-02

3. Resting-state electroencephalography microstates as a marker of photosensitivity in juvenile myoclonic epilepsy;Brain Communications;2024

4. Performing clinical drug trials in children with a rare disease;Essentials of Translational Pediatric Drug Development;2024

5. Diagnosing nonconvulsive status epilepticus: Defining electroencephalographic and clinical response to diagnostic intravenous antiseizure medication trials;Epilepsia;2023-07-10